medicare and glp-1 coverage Medicaid Now Covers GLP-1s for Obesity in Alabama Starting July 1, 2026, Medicare

However, the GLP-1 released naturally after a meal is broken down very quickly by an enzyme called DPP-4, which helps explain why it doesnt produce the same sustained effects as GLP-1 medications

This is an active research area

These are just the things that have worked for me over the past year and a half

Sold under the name Byetta, it was created to treat type 2 diabetes while helping improve blood sugar control after meals

Pfizer, Amgen, and dozens of smaller biotechs are racing to develop GLP-1 alternatives

They help reduce appetite by acting on hunger signals in the brain, slow gastric emptying to promote fullness after meals, and help regulate post-meal blood sugar responses